Sodium Hydroxide → HCID 66660145, compound
Reaction equation
[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[CH3:8][C:9]1[CH:14]=[C:13]([NH:15][C:16]2[NH:20][N:19]=[CH:18][CH:17]=2)[N:12]=[C:11]([N:21]2[CH2:26][C@H:25]([C:27]3[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=3)[CH2:24][C@H:23]([C:33]([O:35]C)=[O:34])[CH2:22]2)[N:10]=1.[OH-].[Na+]>CO>[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[CH3:8][C:9]1[CH:14]=[C:13]([NH:15][C:16]2[NH:20][N:19]=[CH:18][CH:17]=2)[N:12]=[C:11]([N:21]2[CH2:26][C@H:25]([C:27]3[CH:28]=[CH:29][CH:30]=[CH:31][CH:32]=3)[CH2:24][C@H:23]([C:33]([OH:35])=[O:34])[CH2:22]2)[N:10]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To the solution of methyl cis-1-[4-methyl-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]-5-phenylpiperidine-3-carboxylate trifluoroacetate (34.9 mg) in MeOH (3 ml) was added 2 M aqueous solution of NaOH (1 ml). And the mixture was stirred at room temperature for 1 hour. The mixture was concentrated followed by addition of TFA for neutralization. The residue was purified with preparative RP-HPLC to give cis-1-[4-methyl-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]-5-phenylpiperidine-3-carboxylic acid trifluoroacetate (34.9 mg) as a colorless solid.
Workup
- concentrationThe mixture was concentrated
- additionfollowed by addition of TFA for neutralization
- customThe residue was purified with preparative RP-HPLC
Sources & evidence
- ORD record
- ord-d83632bd254c488fb8855b5aad580950
- Source dataset
- uspto-grants-2013_02
- Patent number
- US08367690B2
Reaction notes
Loading…